Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
09/2000
09/05/2000US6113916 Vaccine for response to mycoplasma in swine
09/05/2000US6113914 Osp A proteins of Borrelia burgdorferi subgroups, encoding genes and vaccines
09/05/2000US6113912 Hepatitis A virus vaccines
09/05/2000US6113911 Peptide fragment of respiratory syncytial virus protein G, immunogenic agent, pharmaceutical composition containing it and preparation method
09/05/2000US6113909 Pharmaceutical composition containing a mixed extract of Phellodendron amurense RUPRECHT cortex and Patrinia scabiosaefolia FISCH. for treatment of hepatitis C
09/05/2000US6113906 Water-soluble non-antigenic polymer linkable to biologically active material
09/05/2000US6113905 Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases
09/05/2000US6113902 Polypeptides with amino acid sequences of pro-lys-ile and cyclic epitopes
09/05/2000US6113896 Serine protease inhibitors which inhibit factor x
09/02/2000CA2299893A1 Hiv therapy
08/2000
08/31/2000WO2000050633A1 Method for cloning signal transduction intermediates
08/31/2000WO2000050597A2 Neutrokine-alpha and neutrokine-alpha splice variant
08/31/2000WO2000050562A2 Dna encoding snorf25 receptor
08/31/2000WO2000050460A1 Epitopes or mimotopes derived from the c-epsilon-2 domain of ige, antagonists thereof, and their therapeutic uses
08/31/2000WO2000050453A1 A novel inhibitor of programmed cell death
08/31/2000WO2000050433A2 Staphylococcus aureus q13 polynucleotides, polypeptides and methods of use
08/31/2000WO2000050429A1 Drugs containing phosphoric acid derivatives as the active ingredient
08/31/2000WO2000050428A1 Process for preparing (-)pyridobenzoxazine carboxylic acid derivatives
08/31/2000WO2000050427A1 Optically pure camptothecin analogues
08/31/2000WO2000050424A1 [1,8] naphthyridine derivatives having antiviral activity
08/31/2000WO2000050400A1 2-aminopyridines containing fused ring substituents
08/31/2000WO2000050078A1 Use of bioadhesives and adjuvants for the mucosal delivery of antigens
08/31/2000WO2000050077A1 Immunogens comprising a peptide and a carrier derived from h.influenzae protein d
08/31/2000WO2000050075A2 Enhancement of bactericidal activity of neisseria antigens with oligonucleotides containing cg motifs
08/31/2000WO2000050074A2 Neisserial vaccine compositions and methods
08/31/2000WO2000050072A2 Method for the purification, recovery, and sporulation of cysts and oocysts
08/31/2000WO2000050069A1 A means for the prophylactic and therapeutic treatment of streptococcal infections
08/31/2000WO2000050064A2 Synergistic combination for treatment of viral-mediated diseases
08/31/2000WO2000050051A2 Reovirus for the treatment of cellular proliferative disorders
08/31/2000WO2000040558A8 Aspartic protease inhibitors
08/31/2000WO2000028038A3 Virulence genes and proteins, and their use
08/31/2000WO2000027196A8 Use of gm-csf to inhibit development of drug resistance in hiv+ patients
08/31/2000WO2000023472A3 Interferon-beta fusion proteins and uses
08/31/2000WO2000023465A3 Methods and reagents for isolating biologically active peptides
08/31/2000WO2000018910A9 Moraxella catarrhalis protein, nucleic acid sequence and uses thereof
08/31/2000WO2000012507A3 Pyrrolobenzodiazepines
08/31/2000WO2000012074A3 Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase
08/31/2000DE19908449A1 Kristallmodifikation C von Crystal modification of C 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo-[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino/incarbonsäure
08/31/2000DE19908448A1 Kristallmodifikation D von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo[4.3.0)nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino incarbonsäure Crystal modification D of 8-cyano-1-cyclopropyl-7- (1S, 6S-2,8-diazabicyclo [4.3.0) nonane-8-yl) -6-fluoro-1,4-dihydro-4-oxo-3 -chino incarbonsäure
08/31/2000CA2710788A1 Method for the purification, recovery, and sporulation of cysts and oocysts
08/31/2000CA2689696A1 Microemulsions with adsorbed macromolecules and microparticles
08/31/2000CA2371928A1 Neisserial vaccine compositions and methods
08/31/2000CA2366712A1 A means for the prophylactic and therapeutic treatment of streptococcal infections
08/31/2000CA2366688A1 Use of bioadhesives and adjuvants for the mucosal delivery of antigens
08/31/2000CA2364652A1 ¬1,8| naphthyridine derivatives having antiviral activity
08/31/2000CA2363637A1 Epitopes or mimotopes derived from the c-epsilon-2 domain of ige, antagonists thereof, and their therapeutic uses
08/31/2000CA2363621A1 A novel inhibitor of programmed cell death
08/31/2000CA2363118A1 Immunogens comprising a peptide and a carrier derived from h.influenzae protein d
08/31/2000CA2363112A1 Neutrokine-alpha and neutrokine-alpha splice variant
08/31/2000CA2362906A1 Dna encoding snorf25 receptor
08/31/2000CA2362877A1 Synergistic combination for treatment of viral-mediated diseases
08/30/2000EP1031576A2 Glycopeptide antibiotic derivatives
08/30/2000EP1031570A1 Immuno-modulator exhibiting anti-microbial and anti-mycobacterial activities, method for producing the same and pharmaceutical preparation for treating mycobacterioses as well as lung chronic and non specific conditions, sexually transmitted diseases and the resulting immuno-deficiency
08/30/2000EP1031353A1 Antimycotic compositions
08/30/2000EP1031347A1 Transnasal transport/immunisation with highly adaptable carriers
08/30/2000EP1030852A1 Oxazolidinone derivatives and pharmaceutical compositions
08/30/2000EP1030851A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
08/30/2000EP1030836A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
08/30/2000EP1030819A1 Immunogenic conjugated polypeptide for treatment of herpes simplex virus
08/30/2000EP1030734A1 Encapsulate of active material in alginate matrix
08/30/2000EP1030690A1 Recombinant vaccines comprising immunogenic attenuated bacteria having rpos positive phenotype
08/30/2000EP1030685A2 Essential bacterial genes and their use
08/30/2000EP1030684A1 Modified antibodies with enhanced ability to elicit an anti-idiotype response
08/30/2000EP1030680A1 Treatment of kaposi's sarcoma with il-12
08/30/2000EP1030653A1 Dinitroaniline liposomal formulations and processes for their preparation
08/30/2000EP1030547A1 Methods for preventing and treating bacterial infections using cellulose acetate phthalate or hydroxypropyl methylcellulose phthalate excipients
08/30/2000EP0837692B1 Clostridium difficile toxins and toxoids as mucosal adjuvants
08/30/2000EP0831912A4 Improved formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
08/30/2000EP0831876A4 Method of inhibiting viral replication in eukaryotic cells and of inducing apoptosis of virally-infected cells
08/30/2000EP0759937B1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis c virus
08/30/2000EP0671946B1 Immunoreactive peptides from epstein-barr virus
08/30/2000CN1265149A Use of MHC class II ligands as adjuvant for vaccination and of LAG-3 in cancer treatment
08/30/2000CN1265115A Streptogramines, their prepn. and compsns. containing them
08/30/2000CN1265038A Cellular vesicle called 'exosome', prepn. and use thereof in immune stimulation
08/30/2000CN1265037A Soya extract, process for its prepn. and pharmaceutical compsn.
08/30/2000CN1265007A Disinfectant compsn.
08/29/2000US6111132 Compounds and methods for synthesis and therapy
08/29/2000US6111095 Capped synthetic RNA, analogs, and aptamers
08/29/2000US6111094 Enhanced antisense modulation of ICAM-1
08/29/2000US6111084 Sialyl lewis mimetics produced by solid phase synthesis; antiinflammatory agents
08/29/2000US6111081 Lactoferrin variants and uses thereof
08/29/2000US6111078 Staphylococcus aureus rsbU-1
08/29/2000US6111074 Amino acid sequence of polypeptide from the uridine monophosphate kinase family; for screening bactericides and bacteriostats; for diagnosis and prophylaxis of infections
08/29/2000US6111068 From the p-17 gag protein of human immunodeficiency virus; diagnosis; vaccines; viricides; prophylaxis and therapy for treating or suppressing acquired immune deficiency syndrome
08/29/2000US6111067 Bactericides against grampositive bacteria
08/29/2000US6110971 Fungicide composition comprising a benzoylphenylurea
08/29/2000US6110965 Useful for treating bacterial infections in humans and animals
08/29/2000US6110964 For treating arthritis, inflammatory bowel disease, crohn's disease, emphysema, acute respiratory distress syndrome, asthma chronic obstructive pulmonary disease, alzheimer's disease, organ transplant toxicity, cachexia, cancer
08/29/2000US6110957 Antitumor agent treating cell proliferative disorders such as cancer, dyes, fungicides, bactericides
08/29/2000US6110936 A bactericide treating a bacterial infection in a warm blooded animal
08/29/2000US6110929 Immunomodulators which induce cytokine biosynthesis, including interferon and/or tumor biosynthesis, necrosis factor and inhibit t-helper-type 2 immune response; for treatment of viral and neoplastic diseases
08/29/2000US6110924 Barbituric acid derivatives, processes for their production and pharmaceutical agents containing these compounds
08/29/2000US6110899 LICC of Streptococcus pneumoniae
08/29/2000US6110896 Peptidyl compounds and their therapeutic use
08/29/2000US6110888 Substituted phenols as fragrance, flavor and antimicrobial compounds
08/29/2000US6110735 Method for the preparation of a viral vector by intermolecular homologous recombination
08/29/2000US6110706 Amino acid sequences; for increased immunogenicity
08/29/2000US6110701 DNA encoding precursor of interleukin-1β converting enzyme--related cysteine proteinase II (ICErel -II)
08/29/2000US6110470 Dna molecules with encoded polypeptides with amino acid sequences
08/29/2000US6110469 Hybrid plasmid for 38 kDa antigen of M. tuberculosis
1 ... 1442 1443 1444 1445 1446 1447 1448 1449 1450 1451 1452 1453 1454 1455 1456 1457 1458 1459 1460 1461 1462 ... 1798